The proteasome is a large intracellular protein complex whose main function is proteolytic removal of damaged proteins. It has recently been shown that the proteasome has a crucial role in the pathogenesis of protozoan parasites. We attempted to characterize the proteasome of T. gondii (RH strain). In immunoblot experiments, we showed that MCP231 monoclonal antibody, directed against the human 20S proteasome, labelled homologous proteins in T. gondii with a pattern similar to that observed in mammalian cells. The study of in vitro proteolytic activities showed that chymotrypsin-like activity (the only activity obtained with archaebacteria) was present in Toxoplasma, with K m and specific activity values close to those observed with eukaryotic cells. Immunofluorescence studies showed that the Toxoplasma proteasome predominated in the cytosol.
INTRODUCTION
T he proteasome is a non lysosomal large multisubunit protease complex that is ubiquitous in eukaryotic cells (Bochtler et al, 1999; Dahlmann et al, 1989) . Recent studies have shown that the proteasome is involved in the regulation of key cellular processes such as cell cycle progression, oncogenesis, transcription, development, growth and atrophy of development tissues, substrate flux through metabolic pathways, selective elimination of abnormal proteins, and antigen processing (DeMartino & Slaughter, 1999) . The proteasome plays a key role in the regulation of numerous transcription factors (Hilt & Wolf, 1996) . Electron microscopy and X-ray crystallography of proteasomes from Thermoplasma acidophilum (Baumeister et al, 1998) and Saccharomyces cerevisae (Groll et al, 1997) revealed a cylindrical structure composed of four rings with a narrow channel running through the center of the structure. Each ring consists of seven subunits classified as and β (7 7β7β7 ) on the basis of the simpler proteasome found in the archaebacterium Thermoplasma acido philum.
Proteins are hydrolyzed inside the cylinder sites located on -subunits. In eukaryotic cells, the pro teasome consists of two complexes, namely the 20S proteasome, which forms the proteolytic core, and the 26S proteasome, which consists of the 20S proteasome and a complex regulator (PA 700) which confers ATPdependency and ubiquitinated substrate specificity on the enzyme (Ferell et al, 2000) . The proteasome, previously described as a multicatalytic proteinase com plex, has several distinct peptidase activities. It hydro lyses small peptides whose carboxyl end contains basic, hydrophobic and acidic amino acids (Goldberg, 1995) . The first two specificities are often referred to as the trypsin-like (basic) and chymotrypsin-like (hydro phobic) activities (Arribas & Castano, 1993; Orlowski & Wilk, 1988) . The Thermoplasma proteasome contains only one type of active site and primarily exhibits chy motrypsin-like activity (Dahlmann et al, 1992) . Presumably, during evolution from the prokaryote to the eukaryotic proteasome, the active site developed increasing (but not absolute) specificities (Coux et al, 1996) . Proteases play an important role in the pathogenic mechanisms and differentiation of protozoan parasites; proteasome function has recently been found to play a role in the life cycle progression of the para sites Trypanosoma cruzi (Gonzalez et al., 1996) and T. brucei (Mutomba et al., 1997) . Evidence for the pre sence of proteasomes in Entamoeba histolytica (Scholze et al, 1995) and Leishmania mexicana (Robertson, 1999) has also been reported. The potential of proteasome inhibitors for the treatment of malaria has been highlighted in an experimental model (Gantt et al., 1998) , and Shaw recently reported the inhibition of Toxoplasma gondii growth and replication by proteasome inhibitors (Shaw et al, 2000) . However, little is known of proteasome dis tribution and activity in protozoan parasites. The objectives of this study were to detect proteasomes in Toxoplasma by means of immunoblot and immunofluorescence, and to characterize Toxoplasma peptidase activity in soluble cell extracts in comparison with HeLa cells
MATERIALS AND METHODS

T. GONDII ISOLATION AND CELL CULTURE
T he RH strain of Toxoplasma gondii (Sabin, 1941) was maintained by seriai passage in IOPS/OF1 Swiss male mice (Iffa Credo, France). Tachyzoites were harvested from peritoneal fluid of mice infected four days earlier. Mice were killed and sterile saline was injected into the peritoneal cavity. Tachyzoites were recovered with a syringe. After two filtration steps on 10-and 5-pM Cyclopore track-etched membranes (Whatman), the recovered fluid was centrifuged for 10 min at 1,000 g. The pellet was washed and resuspended in phosphate buffered saline (PBS) ancl centrifuged for 15 min at 20,000 g. The pellet was immediately stored at -20° C for immunoblotting and peptidase assays. NIH-3T3 murine fibroblast cells and HeLa cells were grown on 22-mm 2 glass coverslips (Marienfeld, Nr. 1) in Dulbecco's modified Eagle's medium pH 7.2 (Life Technologies), supplemented with 10 % fetal calf serum, 5 IU/ml penicillin and 5 ug/ml streptomycin at 37° C in humidified 5 % CO,-air. NIH-3T3 murine fibroblasts were infected with tachyzoites (~ 10 5 parasites/ml). Parasites were harvested shortly after complete host-cell lysis and purified by filtration as described above. Free tachyzoites were centrifuged for 10 min at 600 g at room temperature, then washed and deposited on coverslips for immunofluorescence studies (see below).
PROTEIN AND PEPTIDASE ASSAYS
The synthetic fluorogenic substrates succinyl-leucylleucyl-valyl-tyrosyl-4-methylcoumaryl-7-amide (Suc-LLVY-AMC) and succinyl-leucyl-seryl-threonyl-arginyl-4-methylcoumaryl-7-amide (Suc-LSTR-AMC) were purchased from Sigma Chemical Co. The protein concen tration was determined by the Bradford microassay method (Bradford, 1976) using γ-globulin as standard. Stock solutions of the peptide substrates were prepared as follows: LLVY and LSTR were diluted to 20 mM in 100 % DMSO and stored at -20° C. Prior to the proteolytic assay, substrates were diluted in Tris-HCl (50 mM pH 7.5). For the determination of K m -and activity -values, a wide range of LLVY and LSTR concentrations was used (10 to 2,000 uM). Frozen cells were rapidly thawed ancl homogenized at 4° C in 100 pl of 25 mM Tris pH 7.5 then frozen again at -80° C for at least 10 min before rethawing. The combination of hypotonic buffer treatment and repeated freezing caused complete lysis. The protein concentra tion in the reaction mixture was 25 pg per sample. At the start of the proteolytic assay, 50 pl of sample solu tion and 50 pl of substrate were added at 37° C to individual wells of 96-well plates (Nunc) and the fluorescence of the cleavage product was detected at an emission wavelength of 440 nm (excitation wavelength 380 nm) in a Wallac Victor spectrofluorimeter. A standard curve of methylcoumaryl-7-amide (AMC) from 0.5 to 100 pM was prepared to express proteolytic activity as picomoles of AMC per minute and milligram of protein.
ANTIBODIES
MCP-231, a mouse monoclonal antibody against 20S human proteasomes, was obtained from Affiniti Research Products (UK). This antibody reacts with the phylogenetically preserved probox 1 motif shared by all -type subunits (HC2, HC3, HC8, HC9, Iota and Zeta); it reacts with proteasomes of several species, including higher plants, when tested on immunoblots of SDS/PAGE gels, yielding two main bands of 29 and 32 kDa (Hendil et al., 1995; Kopp et al., 1997; Tanaka & Tsurumi, 1997) . A rabbit polyclonal antibody against the 20S proteasome "core" was obtained from Affiniti. This antibody was raised by rabbit immunization with a proteasome preparation from human red blood cells. Western blotting shows bands attributable to "core" subunits at 25-30 kDa. This antibody has been shown to react with human, mouse and yeast proteasomes (Kopp et al., 1997; Tanaka & Tsurumi, 1997) . Rabbit immunserum against liver rat proteasomes was a generous gift from B. Friguet (Conconi et al, 1996) .
POLYACRYLAMIDE GEL ELECTROPHORESIS AND IMMUNOBLOTTING
Immunoblot analysis was performed, in the same experiment, with Toxoplasma gondii, HeLa cells and NIH-3T3 murine fibroblast cells. The protein extracts were prepared at 4° C. The cells were lysed in cold lysis buffer containing 1 % NP40, 0.1 % SDS, 158 mM NaCl, 10 mM Tris pH 7.8, 1 mM phenylmethylsulfonylfluoride and 1 mM Na 3 V0 4 . The cell suspensions were then centrifuged for 20 min at 12,000 g at 4°C. We tested the supernatant and pellet of each cell type. Pellets were homogenized in 100 ul of 25 mM Tris pH 7.8. The protein concentration was determined as described above. Equal amounts of protein (50 ug) from the supernatant and pellet were separated by electrophoresis on SDS-12.5 % polyacrylamide gel and transferred electrophoretically onto a nitrocellulose mem brane. The membrane was incubated for 2 h at room température with 0.25 % gelatin in Tris-buffered saline (10 mM Tris pH 7.5, 150 mM NaCl) containing 0.05 % Tween 20 (TBST) to block nonspecific binding sites. The membrane was then incubated for 1.5 h at room température with the MCP231 anti-20S protéasome monoclonal antibody at 1:2,000 dilution (Affiniti). After extensive washing with TBST, the membrane was incubated for two hours with horseradish peroxidaseconjugated goat anti-mouse IgG (Dako) diluted 1:5,000, then washed with blocking buffer. Proteins were visualized after chemiluminescence staining, following the manufacturer's protocol (ECL, Amersham).
IMMUNOCYTOFLUORESCENCE AND CONFOCAL MICROSCOPY
Cells grown on 22-mm 2 glass coverslips were used for immunocytofluorescence studies. The cells were washed three times with PBS then fixed with 4 % paraformaldehyde in PBS for 10 min. This and ail subsequent steps were performed at room température. Permeabilization was obtained with 1 % Triton X100 in PBS for 5 min. Preincubation for 30 min with PBS + 1 % bovine serum albumin, Fraction V (Sigma) + 1 % nor mal goat serum (GS) was followed by incubation for 1.5 h with proteasome antibody at 1:50 dilution in PBS supplemented with 1 % GS. After washing in PBS supplemented with 1 % BSA, 1 % GS and 0.1 % Triton, the secondary fluorescent antibody (FITC-coupled goat antibody, Sigma) at 1:100 dilution was added for 40 min. Final washes were followed by mounting in Vectashield (Vector, Biosys). Coverslips were examined using a BioRad MRC-1000 device mounted on a Nikon Optiphot II equipped with a 40x objective (Plan apo: NA 1.4). Confocal sections were taken at 0.5-um focus steps. HeLa cells and NIH-3T3 murine fibrobasts were used for comparison. Labeling was considered specifie, as no labeling was observed when the primary antibody was omitted.
RESULTS AND DISCUSSION
IMMUNOBLOTTING S upernatants and pellets of Toxoplasma, HeLa cells and mouse cells (NIH-3T3) containing the same amount of protein (50 ug) were fractionated by SDS-PAGE and blotted to nitrocellulose membranes as described in Material and Methods. We tested a rat brain lysate as specifie control, because immunoblot analysis of purified proteasomes and total brain homogenate with anti-proteasome antibody yields the same pattern (three polypeptide bands around 30 kDa) (Mengual et al, 1996) . Immunoblotting of cell lysates with a mouse Mab MCP231 yielded three different bands at 29, 30 and 32 kDa with T. gondii (Fig. 1) . The two most intensely labeled bands had relative molecular weights of 29 and 32 kDa. An identical pattern was observed with the three animal cell types. Although an equal amount of protein was used, supernatants yielded more-intense bands than pellets, confirming that in Toxoplasma, as in other eukaryotic cells, proteasomes are mainly présent in the cytosolic fraction (Palmer et al, 1996) . The MCP231 antibody reacts with a motif common to ail a-type subunits (HC2, HC3, HC8, HC9, Iota and Zeta), which is phylogenetically preserved (Hendil et al, 1995) . To our knowledge, MCP231 has only been used twice to detect proteasomes in proto zoan parasites. Scholze et al. (1995) showed that MCP231 crossreacted with a soluble E. histolytica extract. Emmerlich et al. (1999) observed immunoblot crossreactivity with MCP231 and Giardia lamblia proteins; MCP231 was the only antibody showing cross-reactivity among several other antibodies directed against the proteasome. We observed a similar lack of cross-reac- tivity with the T. gondii proteasome when we used an antiserum raised against the 20S human red cell pro teasome (see Materials and Methods) in immunoblot experiments. Hua et al. (1996) demonstrated that the 20S proteasome of Trypanosoma brucei showed no cross-reactivity with an antiserum raised against the human 20S proteasome. In addition, To et al. (1997) , using polyclonal antibodies raised against the T. brucei proteasome, observed no cross reactivity with protea somes from rat blood cells. These data point to species-specific differences among proteasomes of proto zoan parasites and mammalian cells.
PROTEOLYTIC ACTIVITIES
Proteolytic activities were measured with fluorogenic peptides as described above. The hydrolytic reaction rate, when tested as a function of the enzyme concen tration and incubation time, was linear, indicating that the enzyme was stable in the assay conditions used (data not shown).
The two peptide substrates tested here exhibited dif ferent properties with regard to substrate requirements and rate of hydrolysis; Lineweaver-Burke plots of pro teolytic activity at different substrate concentrations allowed us to determine the K m of the two substrates. The derived K m and specific activity values are listed in Table I et al., 1996) . We chose to work with crude cell extracts and not with purified proteasomes for the following reasons. Proteasomes in crude cell extracts are more likely to retain their native activities (Driscoll et al, 1992) . Indeed, according to various studies, isolation and purification processes activate the proteasome and lead to structural changes (Ma et al., 1992) . This could explain why Emmerlich et al. (1999) after purification of Giardia lamblia 20S proteasomes, failed to observe significant activity on a range of fluorogenic peptides that are hydrolyzed by the proteasomes of other orga nisms. Published activity values of crude parasite pro teasome extracts are scarce. However, protease activities measured with Suc-LLVY-AMC as substrate have been reported for crude extracts of Entamoeba invadens (Gon zalez et al, 1996) and E. histolytica (Scholze et al., 1995) . The observed activities -0.016 and 0.01 nmol/min.mg, respectively -were close to those we obtained with T. gondii (0.011 nmol/min.mg). We found no publi shed studies using LSTR and crude parasite extracts, but our results suggest that proteasome of T. gondii has lower trypsin-like activity to that of mammalian cell (1598 pmol.min _1 .mg for HeLa versus 76 pmol.min -1 .mg for Toxoplasma).
The proteolytic activity of the Toxo plasma proteasome seems closer to that of prokaryotic proteasomes than that of mammalian proteasomes, the former showing only chymotrypsin-like activity (de Mot et al, 1999 ).
IMMUNOFLUORESCENCE MICROSCOPY
We tested the Mab MCP231 and two rabbit antisera, one against human proteasomes (Affiniti) and the other against rat proteasomes (generously provided by Pr B. Friguet, Paris VI University). As the rabbit anti serum against rat proteasomes gave the clearest immunofluorescence pattern, we only discuss the results obtained with this antibody. In the same experiment, we simultaneously labeled Toxoplasma, HeLa cells and NIH-3T3 murine fibrobast cell crude extracts. The pro teasome of NIH-3T3 murine fibroblast cells and HeLa cells was localized in the cytoplasm and the nucleus. The cytoplasm showed fine granular staining, nuclear staining was stronger, and nucleoli were not labeled ( Fig. 2A) . This pattern is that usually observed with eukaryotic cells (Machiels et al, 1995) . With Toxo-A B plasma (Fig. 2B) , the cytoplasm was labeled while the nucleus was not. In a wide variety of multicellular orga nisms the proteasome is found in both the cytoplasm and the nucleus (Tanaka et al., 1990; Amsterdam et al., 1993) . Subcellular fractionation experiments have gene rally shown that proteasomes are more abundant in the cytosol than in the nucleoplasm (Russel et al, 1999) . Densitometric analysis of western blots obtained in cellfractionation experiments shows that, for the same amount of bulk protein in each fraction, the level of proteasomes is about 10-fold higher in the cytosol than in the nucleus (Palmer et al, 1996) , although the exact ratio varies with the cell type and growth conditions (Peters et al, 1994; Yang et al, 1995) . In addition, immu nofluorescence experiments with mammalian cells have shown that the proteasome ratio varies in a complex manner through the cell cycle (Nannmark et al, 1996; Knecht et al, 1991; Russel et al, 1999) . To detect pos sible changes in the intracellular localization of the Toxoplasma proteasome during mitosis, we stained NIH-3T3 murine fibroblast cells infected by Toxo plasma (data not shown). Despite the intracellular multiplication of Toxoplasma, we observed no nuclear labeling, suggesting that the Toxoplasma proteasome is most abundant in the cytoplasm. Two distribution patterns were seen : fluorescence was dispersed throu ghout the cell in 90 % of parasites, while it showed aggregates of different sizes and shape in 10 % of para sites (Fig. 2B, arrowheads) . The aggregates tended to accumulate at the basal pole of the parasite, where the endoplasmic reticulum is principally located (Hager et al., 1999) . This difference in labeling could also be due to the presence of parasites at different stages of the cell cycle (Reits et al., 1997) . Thus, although the intracellular distribution of mammalian proteasomes remains somewhat controversial (Hirch & Ploegh, 2000) , the T. gondii proteasome seems to be exclusi vely located in the cytoplasm.
CONCLUSION
W e report evidence that T. gondii possesses a proteasome. In immunoblot experiments, T. gondii crude extracts reacted strongly with the monoclonal antibody MCP231 but was only weakly reactive with a polyclonal antibody against the 20S human proteasome. The chymotrypsin-like acti vity of the T. gondii proteasome was similar to that of eukaryotic proteasomes, although the trypsin-like activity of the former was far weaker. Localization stu dies of the Toxoplasma proteasome based on immu nofluorescence and confocal microscopy suggested a principally cytoplasmic location and no nuclear label ling. These data point to differences between the Toxoplasma proteasome and the mammalian 20S pro teasome. Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heatshock protein 90. Archives Biochemistry Biophysics, 1996, 331, 232-240. 
